Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Composition CJC-1295 (Without DAC): 5 mg Ipamorelin: 5 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models Assessment of assay development, including chromatographic separation of co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Product Highlights Dosing Instructions Administer per clinic protocol
Took 4 days to get a response Happy with this product
doi: 10.1016/j.jep.2021.114634 177 YaoZMeiZGeJYangMMiZLanBet al
Oct 22 2008;56(20):9429-33
US$ 26.95
US$ 21.82
US$ 23.45
